PATENT CLAIM ANALYSIS

Application Number: 16120900
Application Type: Utility
Filing Date: 2018-09
Publication Date: 2019-02
Patent Classification: ["424", "452000"]

Abstract:
There is described, inter alia, a coated bead comprising: (a) a granule; (b) a first layer coated over the granule, the first layer comprising a first amount of an active pharmaceutical ingredient comprising a central nervous system stimulant; and (c) a second layer coated over the first layer, the second layer being present in an amount sufficient to substantially delay release of the active pharmaceutical ingredient in the first layer until after the coated bead reaches a distal intestine portion of a subject to whom the coated bead is administered; and (d) the third layer coated over the second layer, the third layer comprising a second amount of the active pharmaceutical ingredient, the third layer being configured to permit substantially immediate release of the active pharmaceutical ingredient comprised therein. Embodiments related to a solid oral pharmaceutical composition are also described.

Claim (Index 17):
The composition of  claim 16 , wherein the oral solid pharmaceutical composition is in the form of a capsule comprising the plurality of coated beads.

Metadata:
- Claim Count in Document: 77.0
- Percentile: 97.0
- Lexical Diversity: 2.46154
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['14928276', '15958413', '16120999', '15343377', '15069734']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7490172915120813
- 35 USC 102 Novelty (BERT): 0.586763983326104
- Combined Prediction Score: 0.7327919606934836
- Mean Citation Score: 415.390078
- Max Citation Score: 512.76935
- Similarity Product: 412.5038010514617

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test